+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Human Microbiome Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape

  • ID: 5462668
  • Report
  • April 2021
  • Region: Global
  • 125 Pages
  • Prodture

FEATURED COMPANIES

  • Bristol-Myers Squibb
  • Dow Inc Chemical
  • DuPont de Nemours, Inc.
  • Evelo Biosciences, Inc.
  • Johnson & Johnson
  • Kaleido Biosciences, Inc.
The global human microbiome therapeutic market is expected to grow at a CAGR of around 42.7% during 2021-2027. This report on global human microbiome therapeutic market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global human microbiome therapeutic market by segmenting the market based on technology, therapeutic area, type, and region. Also, detailed profiles of companies operating in the human microbiome therapeutic market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.



Market Drivers

  • Human Microbiome as a Validated Target for Drug Development
  • Increasing Focus on Human Microbiome Therapeutics Development
  • Increasing Collaboration Between Public-Private Organizations

Market Challenges

  • Stringent Government Regulations
  • Lack of Expertise and Adequate Research

Historical & Forecast Period

  • Base Year: 2020
  • Historical Period: 2016-2019
  • Forecast Period: 2021-2027

Market by Technology

  • Genomics
  • Proteomics
  • Metabolomics

Market by Route of Therapeutic Area

  • Neurological Disorders
  • Dermatological Indications
  • Cancers
  • Metabolic Disorders
  • Gastrointestinal Disorders
  • Others

Market by Type

  • Probiotics and Prebiotics
  • Medical Food
  • Diagnostic Tests
  • Others

Market by Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bristol-Myers Squibb
  • Dow Inc Chemical
  • DuPont de Nemours, Inc.
  • Evelo Biosciences, Inc.
  • Johnson & Johnson
  • Kaleido Biosciences, Inc.
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions

2. Key Insights

3. Global Human Microbiome Therapeutic Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges

4. Global Human Microbiome Therapeutic Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19

5. Global Human Microbiome Therapeutic Market by Technology
5.1. Introduction
5.2. Geonomics
5.3. Proteomics
5.4. Metabolomics

6. Global Human Microbiome Therapeutic Market by Therapeutic Area
6.1 Introduction
6.2 Neurological Disorders
6.3 Dermatological Indications
6.4 Cancers
6.5 Metabolic Disorders
6.6 Gastrointestinal Disorders
6.7 Others

7. Global Human Microbiome Therapeutic Market by Type
7.1 Introduction
7.2 Prebiotics and Probiotics
7.3 Medical Food
7.4 Diagnostic Tests
7.5 Others

8. Global Human Microbiome Therapeutic Market by Region
8.1 Introduction
8.2 Europe
8.3 North America
8.4 Asia Pacific
8.5 Latin America
8.6 Middle East & Africa

9. SWOT Analysis

10. Porter’s Five Forces

11. Market Value Chain Analysis

12. Competitive Landscape
12.1 Competitive Scenario
12.2 Company Profiles
12.2.1 Bristol-Myers Squibb
12.2.2 Dow Inc Chemical
12.2.3 Takeda Pharmaceutical Company Limited
12.2.4 Johnson & Johnson
12.2.5 DuPont de Nemours, Inc.
12.2.6 Merck & Co. Inc.
12.2.7 Pfizer Inc.
12.2.8 Vertex Pharmaceuticals
12.2.9 Evelo Biosciences, Inc.
12.2.10 Kaleido Biosciences, Inc.
12.2.11 Seres Therapeutics, Inc.
12.2.12 PureTech Health PLC

List of Figures
Figure 1: Global Human Microbiome Therapeutic Market (in US$ Million), 2016-2020
Figure 2: Global Human Microbiome Therapeutic Market by Technology, 2020
Figure 3: Global Human Microbiome Therapeutic Market by Therapeutic Area, 2020
Figure 4: Global Human Microbiome Therapeutic Market by Type, 2020
Figure 5: Global Human Microbiome Therapeutic Market by Region, 2020
Figure 6: Global Human Microbiome Therapeutic Market (in US$ Million), 2021-2027
Figure 7: Global Human Microbiome Therapeutic Market by Technology (in %), 2020 & 2027
Figure 8: Global Genomics Human Microbiome Therapeutic Market (in US$ Million), 2016-2020
Figure 9: Global Genomics Human Microbiome Therapeutic Market (in US$ Million), 2021-2027
Figure 10: Global Proteomics Human Microbiome Therapeutic Market (in US$ Million), 2016-2020
Figure 11: Global Proteomics Human Microbiome Therapeutic Market (in US$ Million), 2021-2027
Figure 12: Global Metabolomics Human Microbiome Therapeutic Market (in US$ Million), 2016-2020
Figure 13: Global Metabolomics Human Microbiome Therapeutic Market (in US$ Million), 2021-2027
Figure 14: Global Human Microbiome Therapeutic Market by Therapeutic Area (in %), 2020 & 2027
Figure 15: Global Neurological Disorders Human Microbiome Therapeutic Market (in US$ Million), 2016-2020
Figure 16: Global Neurological Disorders Human Microbiome Therapeutic Market (in US$ Million), 2021-2027
Figure 17: Global Dermatological Indications Human Microbiome Therapeutic Market (in US$ Million), 2016-2020
Figure 18: Global Dermatological Indications Human Microbiome Therapeutic Market (in US$ Million), 2021-2027
Figure 19: Global Cancers Human Microbiome Therapeutic Market (in US$ Million), 2016-2020
Figure 20: Global Cancers Human Microbiome Therapeutic Market (in US$ Million), 2021-2027
Figure 21: Global Metabolic Disorders Human Microbiome Therapeutic Market (in US$ Million), 2016-2020
Figure 22: Global Metabolic Disorders Human Microbiome Therapeutic Market (in US$ Million), 2021-2027
Figure 23: Global Gastrointestinal Disorders Human Microbiome Therapeutic Market (in US$ Million), 2016-2020
Figure 24: Global Gastrointestinal Disorders Human Microbiome Therapeutic Market (in US$ Million), 2021-2027
Figure 25: Global Other Human Microbiome Therapeutic Market (in US$ Million), 2016-2020
Figure 26: Global Other Human Microbiome Therapeutic Market (in US$ Million), 2021-2027
Figure 27: Global Human Microbiome Therapeutic Market by Type (in %), 2020 & 2027
Figure 28: Global Probiotics and Prebiotics Human Microbiome Therapeutic Market (in US$ Million), 2016-2020
Figure 29: Global Probiotics and Prebiotics Human Microbiome Therapeutic Market (in US$ Million), 2021-2027
Figure 30: Global Medical Food Human Microbiome Therapeutic Market (in US$ Million), 2016-2020
Figure 31: Global Medical Food Human Microbiome Therapeutic Market (in US$ Million), 2021-2027
Figure 32: Global Diagnostics Test Human Microbiome Therapeutic Market (in US$ Million), 2016-2020
Figure 33: Global Diagnostics Test Human Microbiome Therapeutic Market (in US$ Million), 2021-2027
Figure 34: Global Other Human Microbiome Therapeutic Market (in US$ Million), 2016-2020
Figure 35: Global Other Human Microbiome Therapeutic Market (in US$ Million), 2021-2027
Figure 36: Global Human Microbiome Therapeutic Market by Region (in %), 2020 & 2027
Figure 37: Europe Human Microbiome Therapeutic Market (in US$ Million), 2016-2020
Figure 38: Europe Human Microbiome Therapeutic Market (in US$ Million), 2021-2027
Figure 39: North America Human Microbiome Therapeutic Market (in US$ Million), 2016-2020
Figure 40: North America Human Microbiome Therapeutic Market (in US$ Million), 2021-2027
Figure 41: Asia Pacific Human Microbiome Therapeutic Market (in US$ Million), 2016-2020
Figure 42: Asia Pacific Human Microbiome Therapeutic Market (in US$ Million), 2021-2027
Figure 43: Latin America Human Microbiome Therapeutic Market (in US$ Million), 2016-2020
Figure 44: Latin America Human Microbiome Therapeutic Market (in US$ Million), 2021-2027
Figure 45: Middle East & Africa Human Microbiome Therapeutic Market (in US$ Million), 2016-2020
Figure 46: Middle East & Africa Human Microbiome Therapeutic Market (in US$ Million), 2021-2027
Figure 47: Market Value Chain

List of Tables
Table 1: Global Human Microbiome Therapeutic Market Portraiture
Table 2: Global Human Microbiome Therapeutic Market by Technology (in US$ Million), 2020 & 2027
Table 3: Global Human Microbiome Therapeutic Market by Therapeutic Area (in US$ Million), 2020 & 2027
Table 4: Global Human Microbiome Therapeutic Market by Type (in US$ Million), 2020 & 2027
Table 5: Global Human Microbiome Therapeutic Market by Region (in US$ Million), 2020 & 2027
Table 6: List of Key Players
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Bristol-Myers Squibb
  • Dow Inc Chemical
  • Takeda Pharmaceutical Company Limited
  • Johnson & Johnson
  • DuPont de Nemours, Inc.
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Vertex Pharmaceuticals
  • Evelo Biosciences, Inc.
  • Kaleido Biosciences, Inc.
  • Seres Therapeutics, Inc.
  • PureTech Health PLC
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll